The global Microcarriers market, valued at US$2.03 billion in 2023, is forecasted to grow at a robust CAGR of 8.0%, reaching US$2.08 billion ...
Julie Levinson Werner and Sandra Halbing of Lowenstein Sandler discuss current DEI-related practices among businesses and ...
The Department of Government Efficiency (DOGE), Elon Musk’s project, has already put HUD programs under a microscope, put $12 ...
Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of ...
Big Tech and pharmaceutical companies are accelerating the implementation of artificial intelligence in the healthcare ...
1d
Zacks Investment Research on MSNMerck & Co., Inc. (MRK) is Attracting Investor Attention: Here is What You Should KnowMerck (MRK) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some of the factors that might affect the near-term performance of the stock. Shares ...
Merck & Co. Inc. closed 36.37% below its 52-week high of $134.63, which the company reached on June 25th.
Humana forecast annual profit slightly below Wall Street estimates on Tuesday, signaling that costs from its ...
Germany’s Merck KGaA is in advanced talks to aquire the U.S. biopharmaceutical company that specializes in rare diseases and cancer.
Merck KGaA, the German healthcare and technology group, is in advanced talks to acquire U.S. cancer and rare diseases ...
Merck has not shied away from splashy takeovers in the past. In 2015, the company agreed to buy U.S. lab equipment supplier ...
TD Cowen downgraded Merck (MRK) to Hold from Buy with a price target of $100, down from $121. The firm says its Buy thesis “broke down” with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results